BEAM
Beam Therapeutics Inc

6,249
Mkt Cap
$2.13B
Volume
1.62M
52W High
$35.25
52W Low
$13.53
PE Ratio
-4.73
BEAM Fundamentals
Price
$20.60
Prev Close
$20.98
Open
$21.40
50D MA
$24.45
Beta
1.90
Avg. Volume
2.55M
EPS (Annual)
-$4.58
P/B
2.20
Rev/Employee
$131,507.25
Loading...
Loading...
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
483

Frequently Asked Questions

What is Market Cap of Beam Therapeutics Inc?
What is the 52-week high for Beam Therapeutics Inc?
What is the 52-week low for Beam Therapeutics Inc?
What is Beam Therapeutics Inc stock price today?
What was Beam Therapeutics Inc stock price yesterday?
What is the PE ratio of Beam Therapeutics Inc?
What is the Price-to-Book ratio of Beam Therapeutics Inc?
What is the 50-day moving average of Beam Therapeutics Inc?
How many employess does Beam Therapeutics Inc has?

Latest BEAM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.